世界中医药
文章摘要
引用本文:石凯峰1,张宁1,刘世巍1,柳诗意1,李韶菁2.高磷血症致慢性肾脏病血管钙化的研究及治疗进展[J].世界中医药,2017,(02):.  
高磷血症致慢性肾脏病血管钙化的研究及治疗进展
Progresses and Research in the Treatment of Vascular Calcification in Chronic Kidney Disease Induced by Hyperphosphatemia
投稿时间:2016-03-25  
DOI:10.3969/j.issn.1673-7202.2017.02.056
中文关键词:  慢性肾脏病  高磷血症  血管钙化  治疗
English Keywords:Chronic kidney disease  Hyperphosphatemia  Vascular calcification  Treatment
基金项目:国家自然科学基金项目(编号:81273747)
作者单位
石凯峰1,张宁1,刘世巍1,柳诗意1,李韶菁2 1 中国中医科学院望京医院北京100102 2 中国中医科学院中药研究所北京100700 
摘要点击次数: 945
全文下载次数: 1141
中文摘要:
      血管钙化是心血管疾病中最常见的病理表现,已经成为慢性肾脏病(Chronic Kidney Disease,CKD)的主要死亡原因,也是慢性肾脏病心血管疾病高发的独立危险因素,高磷血症是慢性肾脏病的常见并发症,高磷可通过多种机制或途径参与血管钙化的发生发展,与慢性肾脏病心血管死亡率密切相关,本文就高磷血症引起血管钙化的机制及中西医治疗作一综述。
English Summary:
      Cardiovascular disease has become the leading cause of death among patients with chronic kidney disease (CKD), and vascular calcification is the most commonly seen pathological change. Vascular calcification is an independent risk factor in cardiovascular disease induced by CKD. Hyperphosphatemia is a common complication of chronic kidney disease. High phosphorus can participate in the development of vascular calcification through a variety of mechanisms or pathways. And it is closely related to the mortality of patients with CKD and cardiovascular. In this paper, the vascular calcification mechanism caused by hyperphosphatemia and its treatment in western medicine and Traditional Chinese medicine are reviewed.
查看全文  查看/发表评论  下载PDF阅读器